ESC Premium Access

A historical perspective: why we opted triple therapy for so long and what made us change our mind.

Congress Presentation

About the speaker

Professor Dominick Joseph Angiolillo

University of Florida College of Medicine – Jacksonville, Jacksonville (United States of America)
26 presentations
2 followers

3 more presentations in this session

Dual versus triple antithrombotic therapy, does trial design make the difference?

Speaker: Professor R. Storey (Sheffield, GB)

Thumbnail

Triple therapy: still an option?

Speaker: Professor K. Huber (Vienna, AT)

Thumbnail

Dual versus triple antithrombotic therapy - The fine art of personalised medicine.

Speaker: Professor R. De Caterina (Pisa, IT)

Thumbnail

Access the full session

Dual versus Triple Antithrombotic Therapy for Patients with Atrial Fibrillation Undergoing Stenting

Speakers: Professor D. Angiolillo, Professor R. Storey, Professor K. Huber, Professor R. De Caterina
Thumbnail

About the event

Image

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb